Ovarian carcinomas with genetic and epigenetic BRCA1 loss have distinct molecular abnormalities.

Autor: Press, Joshua Z.1 drjpress@telus.net, De Luca, Alessandro1 alessandro.deluca@vch.ca, Boyd, Niki1 nboyd@bccancer.bc.ca, Young, Sean1,2 syoung@bccancer.bc.ca, Troussard, Armelle1 atroussa@bccrc.ca, Ridge, Yolanda2 yridge@bccancer.bc.ca, Kaurah, Pardeep2 pkaurah@bccancer.bc.ca, Kalloger, Steve E.3 skalloger@mac.com, Blood, Katherine A.1 kblood@bccrc.ca, Smith, Margaret4 margie.smith@mh.org.au, Spellman, Paul T.5 ptspellman@lbl.gov, Yuker Wang6 Yuker_Wang@affymetrix.com, Miller, Dianne M.7 Dianne.Miller@vch.ca, Horsman, Doug1,4 DHorsman@bccancer.bc.ca, Faham, Malek6 Malek_Faham@affymetrix.com, Gilks, C. Blake1,3 Blake.Gilks@vch.ca, Gray, Joe5 JWGray@lbl.gov, Huntsman, David G.1,2,3 dhuntsma@bccancer.bc.ca
Zdroj: BMC Cancer. 2008, Vol. 8, Special section p1-12. 12p. 1 Color Photograph, 3 Charts, 2 Graphs.
Databáze: Academic Search Ultimate